XRTX (XORTX Therapeutics Inc) Sof foyda

XRTX (XORTX Therapeutics) - kompaniyaning tovar belgisi

Uglerod izi minimal bo'lgan biofarmatsevtika kompaniyasi samarali o'sishi mumkinmi? XORTX Therapeutics Inc. (XRTX) toksik chiqindilarni kamaytirish uchun nefrologiya tadqiqotlarida ESG standartlarini joriy qilmoqda. Biroq, geosiyosiy keskinliklar va sanksiyalar komponentlar yetkazib berilishini to'sib, dori vositalarini ro'yxatdan o'tkazishni sekinlashtirmoqda. Ushbu grafikdagi kompaniyaning joriy sof foydasi operatsion daromad dinamikasini aks ettiradi, bunda ko'rsatkich qiymati -0.00 ni tashkil etib, biznesning haqiqiy moliyaviy barqarorligini ifodalaydi.

XRTX (XORTX Therapeutics Inc.) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

XORTX Therapeutics (XRTX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari XORTX Corp|XRTX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi XORTX Corp|XRTX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati XORTX Therapeutics|XRTX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi xortx.com|XRTX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati XORTX Therapeutics Inc.|XRTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati XORTX Therapeutics Inc|XRTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar XORTX Corp|XRTX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi XORTX Therapeutics|Shoshilinch likvidlik xortx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
XRTX - Sof daromad
Kompaniyaning jamlanma tahlili:XORTX Therapeutics Inc.
XORTX asosiy tovari

XORTX Therapeutics Inc. (XRTX) klinik sinovlarning barqaror sur'atini saqlagan holda, buyraklar davolash uchun gipourikemik agentlarni ishlab chiqishga e'tibor qaratadi. Kompaniyaning sof iqtisodiy effekt tendentsiyasi barcha xarajatlar chegirib tashlanganidan keyingi yakuniy moliyaviy natijani aks ettiradi, bunda yuqoriga yo'nalgan trayektoriya operatsion samaradorlik va aktivlarning ishonchliligining ortayotganini tasdiqlaydi, bu esa investorlarga choraklik hisobotlarning vaqt kechikishlarisiz biznesning real daromadlarini baholash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN: Sof daromad|PHAR (Pharming Corp) - Kompaniya foydasi|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi upstreambio.com (UPB)|Kompaniyaning sof foydasi Zenas Biopharma|IMNM: Yakuniy foyda|Sof daromad GOSS (Gossamer Corp)|Soliqlar to‘langandan keyingi foyda KALV|Septerna Inc - Sof daromad|PVLA: Kompaniya foydasi|SVRA: Sof daromad|Yakuniy foyda RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Sof daromad|ATXS: Soliqlar to‘langandan keyingi foyda|ENGN (enGene Holdings Inc.) - Sof foyda|RAPT: Yakuniy foyda|Sof foyda JBIO|ACRS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Kyverna KYTX|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|VTYX - Sof foyda|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Sof foyda|Kompaniyaning sof daromadi Agenus, Inc AGEN|Sof daromad CLYM (Climb Bio Inc)|Sof foyda zurabio.com (ZURA)|aTyr Pharma - Sof daromad|Soliqlar to‘langandan keyingi foyda ADAG (Adagene Inc)|Ikena Oncology, Inc. - Sof foyda|Sof moliyaviy natija Shattuck Labs, Inc. STTK|EQ: Sof foyda|Sof daromad Connect Biopharma Holdings Limited|Kompaniyaning sof foydasi Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Sof daromad IFRX (InflaRx N.V.)|XFOR (X4 Pharmaceuticals, Inc) - Yakuniy foyda|Sof foyda ACET (Adicet Bio, Inc.)|Sof moliyaviy natija Celularity Inc (CELU)|INMB - Kompaniyaning sof foydasi|BRNS (Barinthus Biotherapeutics PLC) - Kompaniya foydasi|KZR: Sof foyda|Sof daromad SAB Biotherapeutics Inc|Sof daromad AKTX|Enlivex Therapeutics, Ltd. (ENLV) - Sof moliyaviy natija|Sof daromad QTTB (Q32 Bio Inc.)|GeoVax Labs - Kompaniya foydasi|Kompaniyaning sof foydasi Edesa EDSA|Yakuniy foyda IBIO|CARM: Sof daromad|xtlbio.com - Soliqlar to‘langandan keyingi foyda|BOLT (boltbio.com) - Sof daromad|Kompaniya foydasi HCWB|Kompaniyaning sof foydasi Aptevo Therapeutics, Inc.|aimimmuno.com - Soliqdan keyingi foyda|Sof foyda ADTX|GRI (gribio.com) - Yakuniy foyda|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|INDP - Kompaniyaning sof foydasi|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|ALLK (Allakos Inc) - Sof foyda|Sof foyda HOOKIPA|Sof daromad IGMS (IGM Biosciences, Inc.)|ITOS (iTeos Pharma) - Yakuniy foyda|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof moliyaviy natija tcbiopharm.com (TCBP)|THRD - Kompaniyaning sof foydasi